Gastrointestinal lymphoma in Chinese: a retrospective analysis

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Gastrointestinal lymphoma is a significant health concern, particularly in certain populations.
• Understanding the epidemiological and clinical characteristics is vital for effective management.

Purpose of the Study:

• To review and analyze cases of gastrointestinal lymphoma in Chinese patients.
• To evaluate the efficacy of a modified staging classification in predicting prognosis.
• To identify optimal treatment strategies based on disease stage.

Main Methods:

• Retrospective review of 84 Chinese patients with gastrointestinal lymphoma (45 gastric, 39 intestinal).
• Analysis of patient demographics, histology, clinical presentation, and staging.
• Correlation of a modified staging classification with patient prognosis and treatment outcomes.

Main Results:

• Diffuse histiocytic or diffuse large cell lymphoma constituted the majority of cases.
• A high incidence of gastrointestinal bleeding was noted at presentation.
• Intestinal lymphoma patients more frequently presented with advanced disease (Stages III-IV) compared to gastric lymphoma patients (82% vs. 55%, p<0.02).
• Gastric lymphoma demonstrated a better prognosis.
• The modified staging effectively stratified patients into localized (I-II) and advanced (III-IV) disease groups, correlating well with prognosis.
• Intensive therapy yielded good results for localized disease.
• Advanced disease showed poorer treatment outcomes, necessitating improved chemotherapy and earlier diagnosis.
• Surgical resection of primary lesions is recommended to prevent complications like hemorrhage and perforation post-chemotherapy (38% incidence in non-resected cases).

Conclusions:

• A modified staging system effectively predicts prognosis in gastrointestinal lymphoma.
• Early diagnosis and advanced chemotherapy regimens are essential for improving outcomes in advanced gastrointestinal lymphoma.
• Surgical intervention for primary gastrointestinal lesions is recommended to mitigate chemotherapy-related complications.